Joseph Kado

3.2k total citations
75 papers, 1.4k citations indexed

About

Joseph Kado is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Joseph Kado has authored 75 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Public Health, Environmental and Occupational Health, 37 papers in Infectious Diseases and 27 papers in Epidemiology. Recurrent topics in Joseph Kado's work include Streptococcal Infections and Treatments (50 papers), Antimicrobial Resistance in Staphylococcus (28 papers) and Infective Endocarditis Diagnosis and Management (17 papers). Joseph Kado is often cited by papers focused on Streptococcal Infections and Treatments (50 papers), Antimicrobial Resistance in Staphylococcus (28 papers) and Infective Endocarditis Diagnosis and Management (17 papers). Joseph Kado collaborates with scholars based in Australia, Fiji and United Kingdom. Joseph Kado's co-authors include Andrew C. Steer, Jonathan R. Carapetis, Samantha Colquhoun, Michael R. Batzloff, Adam Jenney, Lepani Waqatakirewa, Kim Mulholland, Nigel Wilson, Daniel Engelman and Bo Reményi and has published in prestigious journals such as The Lancet, Circulation and PLoS ONE.

In The Last Decade

Joseph Kado

73 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Kado Australia 24 961 764 586 142 118 75 1.4k
Elaine R. Miller United States 23 322 0.3× 609 0.8× 584 1.0× 151 1.1× 90 0.8× 49 1.6k
Robert Cunney Ireland 24 488 0.5× 527 0.7× 886 1.5× 122 0.9× 61 0.5× 89 1.7k
Teresa Cardoso Portugal 15 509 0.5× 638 0.8× 614 1.0× 114 0.8× 22 0.2× 53 1.4k
Ryan George United Kingdom 20 370 0.4× 531 0.7× 981 1.7× 61 0.4× 75 0.6× 29 1.5k
Brendan McMullan Australia 24 216 0.2× 888 1.2× 868 1.5× 93 0.7× 190 1.6× 103 1.5k
Kent Korgenski United States 27 429 0.4× 372 0.5× 1.4k 2.5× 435 3.1× 65 0.6× 51 2.1k
Joshua Francis Australia 19 351 0.4× 522 0.7× 396 0.7× 50 0.4× 21 0.2× 102 1.0k
Philip Toltzis United States 23 244 0.3× 655 0.9× 673 1.1× 177 1.2× 19 0.2× 86 1.6k
Catherine Lexau United States 15 423 0.4× 558 0.7× 3.7k 6.3× 257 1.8× 64 0.5× 19 4.3k
Efraim Bilavsky Israel 21 200 0.2× 551 0.7× 792 1.4× 168 1.2× 42 0.4× 99 1.4k

Countries citing papers authored by Joseph Kado

Since Specialization
Citations

This map shows the geographic impact of Joseph Kado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Kado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Kado more than expected).

Fields of papers citing papers by Joseph Kado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Kado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Kado. The network helps show where Joseph Kado may publish in the future.

Co-authorship network of co-authors of Joseph Kado

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Kado. A scholar is included among the top collaborators of Joseph Kado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Kado. Joseph Kado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rwebembera, Joselyn, Rachel Webb, Andrea Beaton, et al.. (2025). Acute rheumatic fever. The Lancet. 405(10495). 2164–2178.
2.
3.
4.
Rafai, Eric, Mike Kama, Meciusela Tuicakau, et al.. (2022). Costs of mass drug administration for scabies in Fiji. PLoS neglected tropical diseases. 16(2). e0010147–e0010147. 4 indexed citations
5.
Jenney, Adam, Daniel Engelman, Lucia Romani, et al.. (2021). Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigo. International Journal of Infectious Diseases. 108. 333–339. 5 indexed citations
6.
Jenney, Adam, Daniel Engelman, Lucia Romani, et al.. (2020). Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018–2019. PLoS neglected tropical diseases. 14(12). e0008887–e0008887. 9 indexed citations
7.
Auckland, Kathryn, Balraj Mittal, Benjamin J. Cairns, et al.. (2020). The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans. Scientific Reports. 10(1). 9004–9004. 7 indexed citations
8.
Engelman, Daniel, et al.. (2017). Secondary prevention for screening detected rheumatic heart disease: opportunities to improve adherence. Transactions of the Royal Society of Tropical Medicine and Hygiene. 111(4). 154–162. 10 indexed citations
9.
Engelman, Daniel, Gavin Wheaton, Joseph Kado, et al.. (2016). Screening-detected rheumatic heart disease can progress to severe disease. Heart Asia. 8(2). 67–73. 33 indexed citations
10.
Engelman, Daniel, Joseph Kado, Bo Reményi, et al.. (2016). Focused cardiac ultrasound screening for rheumatic heart disease by briefly trained health workers: a study of diagnostic accuracy. The Lancet Global Health. 4(6). e386–e394. 48 indexed citations
11.
Engelman, Daniel, Joseph Kado, Bo Reményi, et al.. (2016). Screening for rheumatic heart disease: quality and agreement of focused cardiac ultrasound by briefly trained health workers. BMC Cardiovascular Disorders. 16(1). 30–30. 30 indexed citations
12.
Engelman, Daniel, Joseph Kado, Bo Reményi, et al.. (2015). Teaching focused echocardiography for rheumatic heart disease screening. Annals of Pediatric Cardiology. 8(2). 118–118. 21 indexed citations
13.
Parks, Tom, Joseph Kado, Anne Miller, et al.. (2015). Rheumatic Heart Disease-Attributable Mortality at Ages 5–69 Years in Fiji: A Five-Year, National, Population-Based Record-Linkage Cohort Study. PLoS neglected tropical diseases. 9(9). e0004033–e0004033. 33 indexed citations
14.
Colquhoun, Samantha, Joseph Kado, Bo Reményi, et al.. (2014). Echocardiographic screening in a resource poor setting: Borderline rheumatic heart disease could be a normal variant. International Journal of Cardiology. 173(2). 284–289. 36 indexed citations
15.
Kado, Joseph, et al.. (2011). High prevalence of rheumatic heart disease in Fiji detected by echocardiography screening. Journal of Paediatrics and Child Health. 47(7). 473–478. 52 indexed citations
16.
Steer, Andrew C., Joseph Kado, Nigel Wilson, et al.. (2009). High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji.. PubMed. 18(3). 327–35; discussion 336. 58 indexed citations
17.
Steer, Andrew C., Adam Jenney, Joseph Kado, et al.. (2009). Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007. Emerging infectious diseases. 15(2). 216–222. 41 indexed citations
18.
Parks, Tom, Joseph Kado, Samantha Colquhoun, Jonathan R. Carapetis, & Andrew C. Steer. (2009). Underdiagnosis of acute rheumatic fever in primary care settings in a developing country. Tropical Medicine & International Health. 14(11). 1407–1413. 23 indexed citations
19.
Kado, Joseph, et al.. (2005). An Evaluation of Bubble-CPAP in a Neonatal Unit in a Developing Country: Effective Respiratory Support That Can Be Applied By Nurses. Journal of Tropical Pediatrics. 52(4). 249–253. 82 indexed citations
20.
Tiley, Susan, et al.. (2001). Burkholderia cepacia in cystic fibrosis: Novel Australian cluster strain without accelerated respiratory deterioration. Journal of Paediatrics and Child Health. 37(2). 130–136. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine R. Miller Breakdown of academic impact, for papers by Robert Cunney Breakdown of academic impact, for papers by Teresa Cardoso Breakdown of academic impact, for papers by Ryan George Breakdown of academic impact, for papers by Brendan McMullan Breakdown of academic impact, for papers by Kent Korgenski Breakdown of academic impact, for papers by Joshua Francis Breakdown of academic impact, for papers by Philip Toltzis Breakdown of academic impact, for papers by Catherine Lexau Breakdown of academic impact, for papers by Efraim Bilavsky
Rankless by CCL
2026